m-peg-nh2

m-PEG-NH2 (MW 10000) is a PEG-based linker for PROTACs that joins two essential ligands, facilitating the formation of PROTAC molecules. It enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

m-PEG-NH2 (MW 2000) is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

m-PEG-NH2 (MW 20000) is a PEG-based linker for PROTACs that joins two essential ligands, crucial for forming PROTAC molecules, and enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

m-PEG-NH2 (MW 5000) is a PEG-based linker for PROTACs which joins two essential ligands, crucial for forming PROTAC molecules. This linker enables selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

m-PEG-NH2 (MW 1000) is a PEG-based PROTAC linker. m-PEG-amine (MW 1000) can be used to synthesize PROTAC.

m-PEG-NH2 (hydrochloride) (MW 2000) is an osmotically resistant compound utilized in the preparation of hybrid gels with adsorption and size exclusion chromatography (AdSEC) properties. It assists AdSEC gels in separating complex biological mixtures, such as blood, urine, sweat, and tears.

m-PEG-NH2 (MW 20000) is a PROTAC linker that falls under the PEG category. It can be utilized in the synthesis of PROTAC molecules.

m-PEG-NH2 (MW 1000) is a PROTAC linker classified under the PEG category, suitable for synthesizing PROTAC molecules.

mPEG-amine (mPEG-NH2) (MW 10000) is a PROTAC linker from the PEG category, employed in synthesizing PROTAC molecules.

mPEG-amine (MW 750) can synthesize folate-conjugated polymer micelles for encapsulating the anticancer agent 9-nitrocamptothecin . These folate-conjugated polymer micelles serve as effective carriers for poorly soluble anticancer drugs, avoiding macrophages and targeting tumor cells through folate receptor (FR)-mediated endocytosis.

mPEG-amine (mPEG-NH2) (MW 2000) is a type of PROTAC linker that falls under the PEG category and is utilized in the synthesis of PROTAC molecules.

mPEG-amine (mPEG-NH2) (MW 5000) is a modifier that can replace the sulfonic acid portion of dye molecules to enhance the water solubility of long-wavelength voltage-sensitive dyes (VSD) or Pittsburgh (PGH) dyes. It also forms amide bonds with carboxyl groups on microsphere surfaces in the presence of EDC and Sulfo-NHS, creating a PEG coating on fluorescent microspheres for large-scale rotational cytoplasmic flow studies.

mPEG-amine (MW 350) can be used to synthesize folate-conjugated polymeric micelles for encapsulating the anticancer agent 9-nitrocamptothecin . These folate-conjugated polymeric micelles serve as efficient carriers for poorly soluble anticancer drugs, evading macrophages and utilizing folate receptor (FR)-mediated endocytosis to target tumor cells.

mPEG-amine (MW 550) is utilized to synthesize folate-conjugated polymeric micelles designed for encapsulating the anticancer agent 9-nitrocamptothecin . These folate-conjugated polymeric micelles serve as efficient carriers for poorly soluble anticancer drugs, bypass macrophages, and target tumor cells through folate receptor (FR)-mediated endocytosis.

mPEG-amine (MW 3400) can be used to synthesize folate-conjugated polymeric micelles for encapsulating the anticancer drug 9-nitrocamptothecin . These folate-conjugated polymeric micelles serve as efficient carriers for poorly soluble anticancer drugs, allowing them to evade macrophages and target tumor cells through folate receptor (FR)-mediated endocytosis.

mPEG-amine (MW 4000) can synthesize folate-conjugated polymer micelles for encapsulating the anticancer agent 9-nitrocamptothecin . Folate-conjugated polymer micelles serve as effective carriers for poorly soluble anticancer drugs, bypass macrophages, and utilize folate receptor (FR)-mediated endocytosis to target tumor cells.

4-Arm PEG-NH2 (MW 5000) (4-Arm PEG-amine (MW 5000)) is a multi-arm PEG derivative featuring amine groups at the termini of each of the four arms attached to a pentaerythritol core. The reactive primary amine or NH2 groups can rapidly react with activated carboxylic acids, such as NHS esters, to form stable amide bonds.

4-Arm PEG-NH2 HCl (MW 40000) (4-Arm PEG-amine HCL salt (MW 40000)) is a multi-arm PEG derivative featuring amino groups at the termini of its four arms connected to a pentaerythritol core. The reactive primary amine, or NH2 group, readily reacts with activated carboxylic acids such as NHS esters to form stable amide bonds.

8-Arm PEG-NH2 (MW 10000) [8-Arm PEG-Amine (MW 10000)] HCL is a multi-arm PEG derivative, featuring amino groups at the end of each of its eight arms. The reactive primary amine or NH2 groups swiftly react with activated carboxylic acids (such as NHS esters) to form stable amide bonds.

8-Arm PEG-NH2 (MW 40000) (8-Arm PEG-Amine (MW 40000)) HCL is a multi-arm PEG derivative featuring amino groups at the end of each of its eight arms. The reactive primary amine or NH2 groups can rapidly react with activated carboxylic acids (such as NHS esters) to form stable amide bonds.

8-Arm PEG-NH2 (MW 10000) (8-Arm PEG-Amine (MW 10000)) is a multi-arm PEG derivative, with each of its eight arms terminating in an amine group. The reactive primary amine or NH2 groups can rapidly react with activated carboxylic acids (such as NHS esters) to form stable amide bonds.

8-Arm PEG-NH2 (MW 20000) (8-Arm PEG-Amine (MW 20000)) HCL is a multi-arm PEG derivative featuring an amine group at the end of each of its eight arms. The reactive primary amine or NH2 groups can rapidly form stable amide bonds by reacting with activated carboxylic acids, such as NHS esters.

2-Arm PEG-NH2 (MW 10000) (2-Arm PEG-Amine (MW 10000)) is a multi-arm PEG derivative that is applied in peptide modification and can also be utilized for drug delivery.

2-Arm PEG-NH2 (MW 5000) [2-Arm PEG-Amine (MW 5000)] is a multi-arm PEG derivative suitable for peptide modification and drug delivery applications.